The innovators behind an engineered wood substitute, a cancer treatment that relies on electromagnetism, and an effort to turbocharge drug delivery at a cellular level are the winners of grants that aim to accelerate the impact of Notre Dame research.... Read More
Novo Nordisk, a Denmark-based pharmaceutical company, is suing its competitor, Indianapolis-based Eli Lilly and Co., for what it calls “misleading” advertisements comparing the two companies’ GLP-1 drugs.... Read More
A biopharmaceutical company has agreed to settle with the Indiana Public Retirement System and a class of investors after the company was accused of making false statements regarding the safety of one of its drugs.... Read More
Zimmer Biomet alleges that Kristoff Goson, its former vice president of commercial transformation, stole company secrets and breached a non-compete agreement after he became the chief executive of a leading competitor, Pixee Medical.... Read More
The facility, located inside the Novaparke Innovation & Technology Campus in Georgetown, was designed to support and increase the space and defense tech company's ability to meet growing demand for in-space manufacturing and microgravity research.... Read More
Dan Malarek, who has spent almost his entire career with Swiss health care giant Roche Group or an affiliate, will become president and CEO of Indianapolis-based Roche Diagnostics North America on Aug. 1, the company announced Monday... Read More
The deal comes about three months after President Donald Trump signed an executive order directing the FDA and other federal agencies to speed research and loosen restrictions on psychedelic drug treatments for mental health conditions.... Read More
The Indiana Musculoskeletal Health Partnership for the Advancement of Care & Treatment, or IMPACT, consortium seeks to build on the university’s musculoskeletal health research leadership.... Read More
Steve Hoerter, who was previously executive chairman of the company’s board of directors, has succeeded Hawryluk as CEO and board chair.... Read More
The company said the project, which will take place over the next five years, will enhance reliability, enable greater automation and improve efficiency at the plant.... Read More
The Warsaw-based medical technology company will pay $70 million upfront and up to $70 million through Dec. 31, 2031, in revenue-based milestone payments to Pacira BioSciences Inc. for its Iovera device, Pacira said in a news release.... Read More
An Irish medical technology company with its U.S. operations based here is one step closer to launching a pocket-sized brain monitor that uses artificial intelligence to detect seizures in newborns.... Read More
Jasper-based Kimball Electronics Inc. is continuing its push to grow its medical contract manufacturing operations with the acquisition of Helvoet Polymer Technologies, based in the Netherlands.... Read More
Indiana life sciences officials say the recent national rollout of the state's BioHeartland Indiana branding signifies the strengths and assets of the biosciences ecosystem in the state.... Read More
The Purdue Institute for Cancer Research will receive $9.4 million in federal funding to continue its cancer research programs for the next five years.... Read More
The university’s board of trustees on Friday approved elevating the Eli Lilly and Company and Purdue University Research Alliance Center and renaming it the Lilly Purdue Innovation Institute.... Read More
Boston Scientific Corp. plans to spend $138 million to build and equip a 500,000-square-foot medical device distribution and light-manufacturing facility in Plainfield, where it will hire up to 300 people, Indiana Gov. Mike Braun announced Wednesday.... Read More
Through the bankruptcy process, which was filed in the U.S. Bankruptcy Court for the Southern District of Texas, Inotiv said it will reduce its debt by approximately $326 million.... Read More
RayzeBio Inc., a San Diego-based biotech firm that works to develop radiopharmaceutical therapies to treat cancer, is planning to invest $150 million to build two buildings in Whitestown to increase it isotope production and distribution abilities.... Read More
Bothell, Washington-based BioLife Solutions Inc. plans to move its manufacturing and research operations in Indianapolis to a new $16 million facility in Noblesville in 2027, the city announced Tuesday.... Read More
